The Role of Real-World Evidence for Regulatory and Public Health Decision Making for Accelerated Vaccine Deployment
Real-world evidence meeting organized by IABS and Immunity for health
Real-world evidence for monitoring the safety and benefits of vaccination has an essential role to play in the accelerated development and deployment of vaccines. Recently, the COVID-19 pandemic showed the necessity and feasibility of having new vaccines rapidly available. Despite the tremendous success of having several COVID-19 vaccines authorized less than 12 months after the declaration of the COVID-19 global pandemic, many challenges have been faced in both high and low-and-middle income countries. Capitalizing on the massive efforts spent by all stakeholders, it is timely to learn important lessons for the future on how to best use real-world evidence for regulatory and public health decision-making on vaccines and vaccination programmes.
This in-person meeting (Leuven, Belgium) will bring together renowned vaccine experts from national and international public health authorities, regulatory bodies, industry, academia and research organizations for developing recommendations on the best use of real-world evidence for vaccine decision making and a roadmap to further strengthen its use. The meeting brings an exciting mix of information sharing and discussion sessions among all key stakeholders from vaccine development till deployment.
Check out the complete program here
Programme Immunity for health Session- Wednesday 20 of September, 2023
SESSION 6: Experiences using RWE for health economics & for regulatory and public health decision-making on non – COVID-19 vaccines
14:00 Welcome – Immunity for health
14:05 Exploring the Cost-Effectiveness of Respiratory Syncytial Virus (RSV) Preventive Interventions in children with Real-World Evidence (IMI-RESCEU project) – Xiao Li, Health economist, University of Antwerp, Belgium
14:30 Public Health Impact and Return on Investment of Belgium’s Pediatric Immunization Program – Olivier Ethgen, Professor Health Economics, Université de Namur & André Bento, Associate Director, HEOR Manager at MSD
14:55 PERCH (PartnERship to Contrast HPV) project – Hélène De Pauw, Scientist at the Unit of Cancer Epidemiology, Belgian Cancer Centre, Sciensano
15:20 Coffee break
15:50 Health information for policy & decision-making on vaccination – Laura Cornelissen, Scientific Expert and team leader for vaccine-preventable diseases, Department of epidemiology of infectious diseases, Sciensano
16:15 Improving quality of evidence for decision making through innovative design and collaborative studies leveraging RWE platforms– Laurence Torcel- Pagnon, Global Medical Evidence Generation Lead Influenza, Sanofi, Lyon, France
16:40 Closing
Click on the following link to consult the SCIENTIFIC AGENDA and REGISTRATIONS: Real-world-evidence-meeting-2023
Sponsors
Our members & strategic partners
Organizations with expertise in immunology, oncology, vaccinology and infectious diseases, are invited to join Immunity for Health. Together, we build a strong network, fostering innovation in diagnostics, medical devices, immunotherapeutics, and vaccines for humans and animals and across the entire value chain—from R&D to manufacturing, supply, marketing, and beyond. Join us to make impact!
